National Health Act 1953 Amendment determination under sections 85, 85A and 88 pharmaceutical benefits (No. PB 2 of 2009) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 2 of 2009

Amendment determinations under sections 85, 85A and 88 of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under sections 85, 85A and 88 of the National Health Act 1953.

Dated 2nd JANUARY 2009

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — pharmaceutical benefits

1              Commencement

This instrument commences on 1 February 2009.

2              Amendment of PB 114 of 2008

Schedule 1 amends PB 114 of 2008.

Schedule 1        Amendments

1. Part 1 of Schedule 1, item dealing with Alendronic Acid in the form Tablet 70 mg (as alendronate sodium)

in the column headed “Brand” insert in alphabetical order:

Alendronate-GA

1. Part 1 of Schedule 1, item dealing with Amino acid formula with vitamins and minerals without valine, leucine and isoleucine

(a) omit from the columns in the order indicated:

Oral powder 350 g (Ketonex-1) Oral 8 5 Ketonex-1

(b) omit from the columns in the order indicated:

Oral powder 325 g (Ketonex-2) Oral 10 5 Ketonex-2

1. Part 1 of Schedule 1, item dealing with Amlodipine in the form Tablet 5 mg (as besylate)

(a) omit from the column headed “Brand”:

Amlotrust 5

(b) in the column headed “Brand” insert in alphabetical order:

Pharmacor Amlodipine 5

1. Part 1 of Schedule 1, item dealing with Amlodipine in the form Tablet 10 mg (as besylate)

(a) omit from the column headed “Brand”:

Amlotrust 10

(b) in the column headed “Brand” insert in alphabetical order:

Pharmacor Amlodipine 10

1. Part 1 of Schedule 1, item dealing with Atenolol in the form Tablet 50 mg

omit from the column headed “Brand”:

Anselol 50 mg

1. Part 1 of Schedule 1, item dealing with Carvedilol in the form Tablet 3.125 mg

in the column headed “Brand” insert in alphabetical order:

Vedilol 3.125

1. Part 1 of Schedule 1, item dealing with Carvedilol in the form Tablet 6.25 mg

in the column headed “Brand” insert in alphabetical order:

Vedilol 6.25

1. Part 1 of Schedule 1, item dealing with Carvedilol in the form Tablet 12.5 mg

in the column headed “Brand” insert in alphabetical order:

Vedilol 12.5

1. Part 1 of Schedule 1, item dealing with Carvedilol in the form Tablet 25 mg

in the column headed “Brand” insert in alphabetical order:

Vedilol 25

1. Part 1 of Schedule 1, after items dealing with Desmopressin

insert in the columns in the order indicated:

Desvenlafaxine Tablet (extended release) 50 mg (as succinate) Tablet (extended release) 100 mg (as succinate) Oral Oral 28 28 5 5 Pristiq Pristiq

1. Part 1 of Schedule 1, item dealing with Influenza Vaccine

omit from the column headed “Form” (twice occurring):

A/Solomon Islands/3/2006

and substitute:

A/Brisbane/59/2007

1. Part 1 of Schedule 1, item dealing with Lisinopril in the forms Tablet 5 mg and Tablet 20 mg

in the column headed “Brand” insert in alphabetical order:

APO-Lisinopril

1. Part 1 of Schedule 1, item dealing with Meloxicam in the form Capsule 7.5 mg

in the column headed “Brand” insert in alphabetical order:

Movalis 7.5

1. Part 1 of Schedule 1, item dealing with Meloxicam in the form Capsule 15 mg

in the column headed “Brand” insert in alphabetical order:

Movalis 15

1. Part 1 of Schedule 1, item dealing with Metformin in the forms Tablet containing metformin hydrochloride 500 mg and Tablet containing metformin hydrochloride 850 mg

in the column headed “Brand” insert in alphabetical order:

Metformin Ranbaxy

1. Part 1 of Schedule 1, item dealing with Mirtazapine

insert, as first listing, in the columns in the order indicated:

Tablet 15 mg Oral 30 5 Axit 15

1. Part 1 of Schedule 1, item dealing with Protein hydrolysate formula with medium chain triglycerides

omit from the column headed “Form” and the column headed “Brand”:

Pepti-Junior

and substitute:

Pepti-Junior Gold

1. Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 10 mg

in the column headed “Brand” insert in alphabetical order:

Simvastatin-Spirit 10

1. Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 20 mg

in the column headed “Brand” insert in alphabetical order:

Simvastatin-Spirit 20

1. Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 40 mg

in the column headed “Brand” insert in alphabetical order:

Simvastatin-Spirit 40

1. Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 80 mg

in the column headed “Brand” insert in alphabetical order:

Simvastatin-Spirit 80

1. Part 1 of Schedule 1, after item dealing with Sodium Lactate Compound

insert in the columns in the order indicated:

Sorafenib Tablet 200 mg (as tosylate) Oral 120 2 Nexavar

1. Part 1 of Schedule 1, item dealing with Testosterone

omit from the column headed “Brand” (twice occurring):

Organon (Australia) Pty Limited

and substitute:

Schering-Plough Pty Limited

1. Part 1 of Schedule 1, items dealing with Trandolapril in the forms Capsule 1 mg and Capsule 2 mg

omit from the column headed “Brand”:

Odrik

1. Part 1 of Schedule 1, after items dealing with Trimethoprim with Sulfamethoxazole

insert in the columns in the order indicated:

Triptorelin Powder for I.M. injection (prolonged release) 3.75 mg (as embonate) with solvent, syringe and needles Powder for I.M. injection (prolonged release) 11.25 mg (as embonate) with solvent, syringe and needles Injection Injection 1 1 5 1 Diphereline Diphereline

1. Part 1 of Schedule 1, after item dealing with Vinorelbine

insert in the columns in the order indicated:

Voriconazole Tablet 50 mg Tablet 200 mg Oral Oral 56 56 . . . . Vfend Vfend

1. Part 2 of Schedule 1, item dealing with Simvastatin in the form Tablet 10 mg

in the column headed “Brand” insert in alphabetical order:

Simvastatin-Spirit 10

1. Part 2 of Schedule 1, item dealing with Simvastatin in the form Tablet 20 mg

in the column headed “Brand” insert in alphabetical order:

Simvastatin-Spirit 20

1. Part 2 of Schedule 1, item dealing with Simvastatin in the form Tablet 40 mg

in the column headed “Brand” insert in alphabetical order:

Simvastatin-Spirit 40

1. Part 2 of Schedule 1, item dealing with Simvastatin in the form Tablet 80 mg

in the column headed “Brand” insert in alphabetical order:

Simvastatin-Spirit 80